Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Post-update, the page shows Revision: v3.6.6, replacing v3.6.5. This indicates a small behind-the-scenes update to the page software without changing displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T21:59:13.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The site now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor platform version update.
    Difference
    0.1%
    Check dated 2026-08-09T12:29:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small metadata/version change.
    Difference
    0.1%
    Check dated 2026-07-26T00:08:49.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.2 to v3.6.3, representing a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-04T13:20:16.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision/build identifier was updated from v3.6.0 to v3.6.2, indicating a minor update to the page build. This change does not alter the study details or eligibility information presented on the page.
    Difference
    0.1%
    Check dated 2026-06-27T07:44:41.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Editorial updates on the study record page add sponsor identifiers (Aiping Zhou and Chinese Academy of Medical Sciences) and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). The revision tag is updated to v3.6.0, and some older verification-related lines were removed.
    Difference
    2%
    Check dated 2026-06-13T01:31:55.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.